Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6890429 | 1.00 | MAPT (0.48) | MAPTSMN1; SMN2TSHRALDH1A1KMT2A | |
| SCHEMBL4347265 | 1.00 | MAPT (0.48) | MAPTSMN1; SMN2TSHRALDH1A1KMT2A | |
| SCHEMBL14521227 | 1.00 | MAPT (0.48) | MAPTSMN1; SMN2TSHRALDH1A1KMT2A | |
| SCHEMBL15612333 | 0.91 | MAPT (0.45) | MAPTSMN1; SMN2TSHRALDH1A1KMT2A | |
| SCHEMBL15612276 | 0.91 | MAPT (0.45) | MAPTSMN1; SMN2TSHRALDH1A1KMT2A | |
| SCHEMBL14602769 | 0.91 | MAPT (0.45) | MAPTSMN1; SMN2TSHRALDH1A1KMT2A | |
| Acrylamide SCHEMBL9395827 | 0.89 | ALDH1A1 (0.44) | MAPTSMN1; SMN2TSHRALDH1A1KMT2A | |
| SCHEMBL9081926 | 0.89 | ALDH1A1 (0.43) | MAPTSMN1; SMN2TSHRALDH1A1KMT2A | |
| SCHEMBL15627332 | 0.85 | SMN1; SMN2 (0.48) | MAPTSMN1; SMN2TSHRALDH1A1KMT2A | |
| SCHEMBL27958358 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 849 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260072020-A1 | PRINTABLE MOLECULE-SELECTIVE CORE-SHELL NANOPARTICLES FOR WEARABLE AND IMPLANTABLE SENSING | CALIFORNIA INST OF TECHN (US) | 2026-03-12 | — | — | US | claimed |
| US-20250158067-A1 | SECONDARY BATTERY AND METHOD FOR MANUFACTURING SAME | LG ENERGY SOLUTION, LTD. (KR) | 2025-05-15 | — | — | US | claimed |
| CN-119968468-A | Submicron precision large-scale replication method for DNA chip | 拓扑基因股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| US-20240425742-A1 | High Temperature Suspension Additive For Wellbore Treatments | HALLIBURTON ENERGY SERVICES, INC. (US) | 2024-12-26 | — | — | US | claimed |
| WO-2024263211-A1 | HIGH TEMPERATURE SUSPENSION ADDITIVE FOR WELLBORE TREATMENTS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2024-12-26 | — | — | WO | claimed |
| CN-222053456-U | Circuit board and terminal equipment of audio power amplifier circuit blind hole-free | 深圳微步信息股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-4451453-A1 | SECONDARY BATTERY AND METHOD FOR MANUFACTURING SAME | LG Energy Solution, Ltd. (KR) | 2024-10-23 | — | — | EP | claimed |
| WO-2024174916-A1 | METHOD FOR CONSTRUCTING SINGLE CELL LIBRARY CONTAINING TISSUE LOCATION INFORMATION AND SEQUENCING METHOD | 北京寻因生物科技有限公司 | 2024-08-29 | — | — | WO | claimed |
| CN-118541865-A | Secondary battery and method for manufacturing the same | 株式会社LG新能源 | 2024-08-23 | — | — | CN | claimed |
| CN-113093234-B | Beidou dual-mode position tracking data terminal | 河北晶禾电子技术股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| EP-0296926-A1 | Composite polymers, their preparation and their use in liquid chromatography | I.B.F. (FR) | 1988-12-28 | — | — | EP | claimed |
| US-4794083-A | WITH CARBODIMIDE ON A POLYMER WITH AMINO OR CARBOXY FUNCTJONAL GROUPS | REANAL FINOMVEGYSZERGYAR (HU) | 1988-12-27 | — | — | US | claimed |
| US-4790919-A | PHOTOPOLYMERIZED ACRYLAMIDES; CONTROLLED POROSITY GRADIENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-12-13 | — | — | US | claimed |
| US-4704198-A | INITIATOR-FREE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-03 | — | — | US | claimed |
| EP-0169397-A1 | Process for preparation of electrophoresis gel material | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-01-29 | — | — | EP | claimed |
| EP-0073174-B1 | COMPOSITE OF RUBBER AND METAL REINFORCEMENT THEREFOR | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1986-01-02 | — | — | EP | claimed |
| EP-0159694-A2 | Radiation process for preparation of electrophoresis gel material | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-10-30 | — | — | EP | claimed |
| US-4539200-A | CLEANING WOUNDS CROSSLINKED POLYAMIDES | THE KENDALL COMPANY (US) | 1985-09-03 | — | — | US | claimed |
| US-4486532-A | IMMOBILIZATION OF FUMARASE-PRODUCING MICROORGANISM | TNANBE SEIYAKU CO., LTD. (JP) | 1984-12-04 | — | — | US | claimed |
| US-4192784-A | N-(TRIS(HYDROXYMETHYL)METHYL)ACRYLAMIDE OR THE METHACRYLAMIDE COPOLYMERS, BIOLOGICAL IMMOBILIZATION | MAR-PHA SOCIETE D'ETUDES ET D'EXPLOITATION DE MARQUES (FR) | 1980-03-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260072020-A1 | PRINTABLE MOLECULE-SELECTIVE CORE-SHELL NANOPARTICLES FOR WEARABLE AND IMPLANTABLE SENSING | MIF, HMOX2, HMOX1 | MAPT 3003/4885SMN1; SMN2 2725/4885TSHR 3290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.